Patients with rheumatoid arthritis (RA), axial spondylarthritis (axSpA) or psoriatic arthritis (PsA) need to be seen rapidly in case of flare. Physical activity data (steps collected through a wearable) can be analysed using artificial intelligence (AI) to detect disease flares.
To assess the impact of a personalised prioritisation system driven by physical activity data collected passively by wearables from patients with RA, axSpA or PsA on timeliness of appointments, patient outcomes (disease activity scores, health-related quality of life and treatment changes) and use of healthcare resources over a 1-year period.
Full study completion for APPRISE within a timeframe of 36 months:
As part of the steering committee, three PRPs participate in all phases of this study from the beginning: in the development of the protocol, the assessment of feasibility and acceptability, the wording of the patient CRF, the co-writing of the patient’ information documents, the planning and interpretation of the analyses, the writing of and co-authorship on publications and the dissemination in lay language and public channels.